Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.07 -0.06 (-1.45%)
As of: Oct 1, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Net Equity Issued and Repurchased (2020 - 2025)

Updated

Recursion Pharmaceuticals' Net Equity Issued and Repurchased was $133.38 million in Q4 2025, compared with $11.03 million a year earlier and down 47.6% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

For FY2025, Net Equity Issued and Repurchased at Recursion Pharmaceuticals came in at $528.86 million, up 76.0% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $300.42 million in FY2024 (+134.5%), $128.09 million in FY2023 (-10.9%), $143.71 million in FY2022 (-69.0%) and $462.9 million in FY2021 (+93.6%).
  • Quarterly Net Equity Issued and Repurchased has moved between $1.95 million (Q1 2023) and $460.75 million (Q2 2021) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last five quarters, with growth averaging 105.3%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2024 (growth of 458.7%); the worst was Q2 2022 (a decline of 99.4%).
  • Per Business Quant data, RXRX's Net Equity Issued and Repurchased in the three quarters before Q4 2025 was $254.46 million (Q3 2025), $100 million (Q2 2025) and $41.02 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Recursion Pharmaceuticals 2.21 Bn -397.37 Mn -3.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 133.38 Mn
Sep 30, 2025 254.46 Mn
Jun 30, 2025 100.00 Mn
Mar 31, 2025 41.02 Mn
Dec 31, 2024 11.03 Mn
Sep 30, 2024 16.97 Mn
Jun 30, 2024 261.55 Mn
Mar 31, 2024 10.87 Mn
Dec 31, 2023 78.09 Mn
Sep 30, 2023 44.24 Mn
Jun 30, 2023 3.81 Mn
Mar 31, 2023 1.95 Mn
Dec 31, 2022 136.56 Mn
Sep 30, 2022 2.36 Mn
Jun 30, 2022 2.69 Mn
Mar 31, 2022 2.11 Mn
Jun 30, 2021 460.75 Mn
Mar 31, 2021 2.15 Mn
Dec 31, 2020 9.60 Mn
Sep 30, 2020 229.51 Mn
API Access

Recursion Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RXRX&period=max&api_key=YOUR_API_KEY